Efficacy and Safety of Lixivaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease
Clinical trial NCT04064346 · TERMINATED
Trial details
- NCT number
- NCT04064346
- Sponsor
- Palladio Biosciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2022-08-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.